Investor Relations

CO.DON AG stands for open, dependable communications with shareholders,  financial analysts and media. By providing transparent, timely information we create a positive foundation for developing a trusted relationship with the financial community.

Why not find out about our company's rapid development and ambitious targets? As a shareholder you too will benefit from the positive long-term  performance of our market capitalisation.

We are happy to answer your questions on our corporate development and can provide you with further relevant information.

6 April 2018 - CO.DON CO.DON share: WARBURG RESEARCH GmbH confirms buy recommendation and target price for CO.DON share

The Hamburg-based research house WARBURG RESEARCH GmbH has confirmed its buy recommendation and the target price of EUR 13.50 per share   following the announcement of the positive outcome of a long-term follow-up phase II clinical trial named "co.dis"

 

The complete update of the research study can be found here.

5 April 2018 - CO.DON share: Sphene Capital GMBH confirms buy recommendation and target price for CO.DON share

The Munich-based research house Sphene Capital GmbH has confirmed its buy recommendation and its target price of EUR 12.50 per share following the announcement of the completion of the clinical study Phase II.

 

The complete update of the research study (German Language) can be found here.